Ureteral protection during microwave ablation of renal cell carcinoma: combined use of pyeloperfusion and hydrodissection
PDF
Cite
Share
Request
Interventional Radiology - Technical Note
P: 388-391
November 2018

Ureteral protection during microwave ablation of renal cell carcinoma: combined use of pyeloperfusion and hydrodissection

Diagn Interv Radiol 2018;24(6):388-391
1. Division of Interventional Radiology, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA
No information available.
No information available
Received Date: 05.04.2018
Accepted Date: 14.06.2018
PDF
Cite
Share
Request

ABSTRACT

A 56-year-old female with past medical history of thrombotic microangiopathy presented to her physician with nonspecific abdominal pain. A magnetic resonance imaging scan was obtained, which revealed a 3.1 cm mass arising from medial lower pole of the left kidney that was subsequently shown to be renal cell carcinoma by percutaneous biopsy. Because of her history of thrombotic microangiopathy and other comorbidities, she was deemed a nonsurgical candidate and was therefore referred to interventional radiology for thermal ablation. Computed tomography (CT)-guided microwave ablation was performed with the combined use of pyeloperfusion and hydrodissection for maximal ureteral protection. Follow-up unenhanced CT scan obtained one month after ablation showed a normal collecting system without evidence of hydronephrosis or urinoma.